|
US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
|
US6117643A
(en)
*
|
1997-11-25 |
2000-09-12 |
Ut Battelle, Llc |
Bioluminescent bioreporter integrated circuit
|
|
JP2002534139A
(ja)
*
|
1999-01-05 |
2002-10-15 |
マサチューセッツ・アイ・アンド・イア・インファーマリー |
網膜と脈絡膜への経強膜徐放性薬剤標的送達
|
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
ATE283013T1
(de)
|
1999-10-21 |
2004-12-15 |
Alcon Inc |
Medikamentenzuführvorrichtung
|
|
US6416777B1
(en)
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
|
PT1221918E
(pt)
|
1999-10-21 |
2005-06-30 |
Alcon Inc |
Administracao de drogas sub-tenon
|
|
US7943162B2
(en)
*
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
|
US6331313B1
(en)
*
|
1999-10-22 |
2001-12-18 |
Oculex Pharmaceticals, Inc. |
Controlled-release biocompatible ocular drug delivery implant devices and methods
|
|
US20040208910A1
(en)
*
|
2000-04-26 |
2004-10-21 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of adrenergic agents
|
|
US20040115268A1
(en)
*
|
2000-04-26 |
2004-06-17 |
Control Delivery Systems, Inc. |
Systemic delivery of antiviral agents
|
|
US20040175410A1
(en)
*
|
2000-04-26 |
2004-09-09 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors
|
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
|
USRE44145E1
(en)
|
2000-07-07 |
2013-04-09 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
|
|
US7420030B2
(en)
*
|
2000-09-08 |
2008-09-02 |
The Board Of Regents Of The University Of Texas System |
Aminopeptidase A (APA) targeting peptides for the treatment of cancer
|
|
US20040170955A1
(en)
|
2000-09-08 |
2004-09-02 |
Wadih Arap |
Human and mouse targeting peptides identified by phage display
|
|
US20050074747A1
(en)
*
|
2000-09-08 |
2005-04-07 |
Wadih Arap |
Biopanning and rapid analysis of selective interactive ligands (brasil)
|
|
US7452964B2
(en)
|
2001-09-07 |
2008-11-18 |
Board Of Regents, The University Of Texas System |
Compositions and methods of use of targeting peptides against placenta and adipose tissues
|
|
AU2002232399A1
(en)
*
|
2000-11-03 |
2002-05-15 |
Control Delivery Systems |
Improved device and method for treating conditions of a joint
|
|
AU2002236495B2
(en)
|
2000-11-29 |
2006-05-11 |
Allergan, Inc. |
Intraocular implants for preventing transplant rejection in the eye
|
|
EP1345588A2
(en)
*
|
2000-12-29 |
2003-09-24 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices
|
|
JP2004521882A
(ja)
*
|
2001-01-03 |
2004-07-22 |
ボシュ・アンド・ロム・インコーポレイテッド |
組立式透過性プラグを備えた徐放薬剤送達装置
|
|
EP1847255A3
(en)
*
|
2001-01-03 |
2009-03-04 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with coated drug cores
|
|
EP1404295B1
(en)
*
|
2001-01-03 |
2007-10-10 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with coated drug cores
|
|
ES2320533T3
(es)
|
2001-01-03 |
2009-05-25 |
BAUSCH & LOMB INCORPORATED |
Dispositivos de administracion de farmacos de liberacion sostenida con multiples agentes.
|
|
US6991808B2
(en)
*
|
2001-01-26 |
2006-01-31 |
Bausch & Lomb Inc. |
Process for the production of sustained release drug delivery devices
|
|
US6713081B2
(en)
*
|
2001-03-15 |
2004-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Ocular therapeutic agent delivery devices and methods for making and using such devices
|
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
|
WO2002087645A1
(en)
|
2001-05-01 |
2002-11-07 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions
|
|
US20050215727A1
(en)
|
2001-05-01 |
2005-09-29 |
Corium |
Water-absorbent adhesive compositions and associated methods of manufacture and use
|
|
AU2002316053A1
(en)
*
|
2001-05-01 |
2002-11-11 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Two-phase, water-absorbent bioadhesive composition
|
|
US20050113510A1
(en)
|
2001-05-01 |
2005-05-26 |
Feldstein Mikhail M. |
Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
|
|
US8206738B2
(en)
|
2001-05-01 |
2012-06-26 |
Corium International, Inc. |
Hydrogel compositions with an erodible backing member
|
|
US8541021B2
(en)
*
|
2001-05-01 |
2013-09-24 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions demonstrating phase separation on contact with aqueous media
|
|
US8840918B2
(en)
|
2001-05-01 |
2014-09-23 |
A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences |
Hydrogel compositions for tooth whitening
|
|
WO2002089767A1
(en)
|
2001-05-03 |
2002-11-14 |
Massachusetts Eye And Ear Infirmary |
Implantable drug delivery device and use thereof
|
|
EP1404297B1
(en)
*
|
2001-06-12 |
2011-04-27 |
The Johns Hopkins University School Of Medicine |
Reservoir device for intraocular drug delivery
|
|
CA2454357A1
(en)
*
|
2001-07-18 |
2003-01-30 |
Wadih Arap |
An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration
|
|
DE60214697T2
(de)
*
|
2001-07-23 |
2007-09-13 |
Alcon Inc. |
Vorrichtung zur freisetzung eines ophthalmischen arzneimittels
|
|
DE60217679T2
(de)
|
2001-07-23 |
2007-10-25 |
Alcon Inc. |
Vorrichtung zur freisetzung eines ophthalmischen arzneimittels
|
|
US7749528B2
(en)
*
|
2001-08-29 |
2010-07-06 |
Ricardo Azevedo Pontes De Carvalho |
Implantable and sealable medical device for unidirectional delivery of therapeutic agents to tissues
|
|
JP2005501602A
(ja)
|
2001-08-29 |
2005-01-20 |
カルバーリョ、リカルド エイ．ピー． デ |
治療薬を組織に一方向送達するための封鎖可能な移殖型装置
|
|
US20040048243A1
(en)
*
|
2001-09-07 |
2004-03-11 |
Wadih Arap |
Methods and compositions for in vitro targeting
|
|
US8507445B2
(en)
*
|
2001-09-07 |
2013-08-13 |
Board Of Regents, The University Of Texas System |
Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
|
|
US7671010B2
(en)
*
|
2002-08-30 |
2010-03-02 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
|
|
US20030158598A1
(en)
*
|
2001-09-17 |
2003-08-21 |
Control Delivery Systems, Inc. |
System for sustained-release delivery of anti-inflammatory agents from a coated medical device
|
|
JP4387798B2
(ja)
*
|
2002-01-31 |
2009-12-24 |
ベステルガールド フランドセン ソシエテ アノニム |
積層殺虫剤ディスペンサー
|
|
US20030229333A1
(en)
*
|
2002-02-22 |
2003-12-11 |
Control Delivery Systems, Inc. |
Methods for treating otic disorders
|
|
CA2478772C
(en)
*
|
2002-03-11 |
2011-01-18 |
Alcon, Inc. |
Implantable drug delivery system
|
|
CA2482904A1
(en)
*
|
2002-04-18 |
2003-10-23 |
Lynkeus Biotech Gmbh |
Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification
|
|
AU2003234294A1
(en)
*
|
2002-05-02 |
2003-11-17 |
Control Delivery Systems, Inc. |
Device and method for treating conditions of a joint
|
|
WO2003092665A2
(en)
*
|
2002-05-02 |
2003-11-13 |
Massachusetts Eye And Ear Infirmary |
Ocular drug delivery systems and use thereof
|
|
US8871241B2
(en)
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
|
WO2003094888A1
(en)
*
|
2002-05-07 |
2003-11-20 |
Control Delivery Systems, Inc. |
Processes for forming a drug delivery device
|
|
EP1507826A4
(en)
|
2002-05-17 |
2007-11-07 |
Othera Pharmaceuticals Inc |
IMPROVING THE EVOLUTION OF CATARACTS AND OTHER OPHTHALMIC DISEASES
|
|
US20070184089A1
(en)
*
|
2002-07-15 |
2007-08-09 |
Alcon, Inc. |
Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use
|
|
DE60318446T2
(de)
*
|
2002-07-15 |
2008-05-21 |
Alcon Inc. |
Nichtpolymere lipophile pharmazeutische implantat-zusammensetzungen für die intraokulare anwendung
|
|
US7148342B2
(en)
|
2002-07-24 |
2006-12-12 |
The Trustees Of The University Of Pennyslvania |
Compositions and methods for sirna inhibition of angiogenesis
|
|
WO2004036182A2
(en)
*
|
2002-10-17 |
2004-04-29 |
Control Delivery Systems, Inc. |
Methods for monitoring treatment of disease
|
|
WO2004043435A2
(en)
*
|
2002-11-13 |
2004-05-27 |
Control Delivery Systems, Inc. |
Systemic delivery of antiviral agents
|
|
CA2453013C
(en)
*
|
2002-12-13 |
2011-02-15 |
Gary W. Cleary |
Dermal, transdermal, mucosal or transmucosal ingredient delivery devices
|
|
CA2510296A1
(en)
*
|
2002-12-20 |
2004-07-15 |
Control Delivery Systems, Inc. |
Steroid compositions for intraocular use
|
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
|
DE602004028587D1
(de)
|
2003-01-16 |
2010-09-23 |
Univ Pennsylvania |
ZUSAMMENSETZUNGEN UND VERFAHREN ZUR siRNA-HEMMUNG VON ICAM-1
|
|
WO2004066980A2
(en)
*
|
2003-01-24 |
2004-08-12 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors
|
|
CN1741792A
(zh)
*
|
2003-01-24 |
2006-03-01 |
控制递送系统有限公司 |
经眼部递送肾上腺素能剂的持续释放系统和方法
|
|
CA2513751C
(en)
*
|
2003-01-24 |
2012-01-10 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of adrenergic agents
|
|
WO2004066939A2
(en)
*
|
2003-01-27 |
2004-08-12 |
Sarnoff Corporation |
Controlled-release drug delivery system
|
|
WO2004073551A2
(en)
*
|
2003-02-18 |
2004-09-02 |
Massachusetts Eye And Ear Infirmary |
Transscleral drug delivery device and related methods
|
|
US9445901B2
(en)
*
|
2003-03-12 |
2016-09-20 |
Deger C. Tunc |
Prosthesis with sustained release analgesic
|
|
US20050261668A1
(en)
*
|
2003-03-28 |
2005-11-24 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
US7037521B2
(en)
*
|
2003-03-28 |
2006-05-02 |
Bausch & Lomb Incorporated |
Using a laser for cutting a hole in a capsule for controlled drug delivery
|
|
US7589107B2
(en)
|
2003-05-19 |
2009-09-15 |
Othera Holding, Inc. |
Amelioration of vitrectomy-induced cataracts
|
|
US7825134B2
(en)
*
|
2003-05-19 |
2010-11-02 |
Othera Holding, Inc. |
Amelioration of cataracts, macular degeneration and other ophthalmic diseases
|
|
US8715243B2
(en)
*
|
2003-06-16 |
2014-05-06 |
Ethicon Endo-Surgery, Inc. |
Injection port applier with downward force actuation
|
|
US7553298B2
(en)
*
|
2003-12-19 |
2009-06-30 |
Ethicon Endo-Surgery, Inc. |
Implantable medical device with cover and method
|
|
US7862546B2
(en)
*
|
2003-06-16 |
2011-01-04 |
Ethicon Endo-Surgery, Inc. |
Subcutaneous self attaching injection port with integral moveable retention members
|
|
US7561916B2
(en)
|
2005-06-24 |
2009-07-14 |
Ethicon Endo-Surgery, Inc. |
Implantable medical device with indicator
|
|
US9592258B2
(en)
|
2003-06-27 |
2017-03-14 |
DePuy Synthes Products, Inc. |
Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
|
|
US9572840B2
(en)
|
2003-06-27 |
2017-02-21 |
DePuy Synthes Products, Inc. |
Regeneration and repair of neural tissue using postpartum-derived cells
|
|
EP2399990B1
(en)
|
2003-06-27 |
2015-07-22 |
DePuy Synthes Products, Inc. |
Cells derived from post-partum umbilical cord for use in treatment of disease of the heart and circulatory system
|
|
US7875272B2
(en)
|
2003-06-27 |
2011-01-25 |
Ethicon, Incorporated |
Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
|
|
US8491883B2
(en)
*
|
2003-06-27 |
2013-07-23 |
Advanced Technologies And Regenerative Medicine, Llc |
Treatment of amyotrophic lateral sclerosis using umbilical derived cells
|
|
US8790637B2
(en)
|
2003-06-27 |
2014-07-29 |
DePuy Synthes Products, LLC |
Repair and regeneration of ocular tissue using postpartum-derived cells
|
|
US8518390B2
(en)
|
2003-06-27 |
2013-08-27 |
Advanced Technologies And Regenerative Medicine, Llc |
Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells
|
|
US20040265356A1
(en)
*
|
2003-06-30 |
2004-12-30 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
US20050054586A1
(en)
*
|
2003-06-30 |
2005-03-10 |
Bartels Stephen P. |
Treatment of ophthalmic disorders
|
|
US7888546B2
(en)
*
|
2003-07-03 |
2011-02-15 |
Corium International, Inc. |
Wound dressing, ingredient delivery device and IV hold-down, and method relating to same
|
|
KR20060082792A
(ko)
*
|
2003-07-10 |
2006-07-19 |
알콘, 인코퍼레이티드 |
안과용 약물 전달 장치
|
|
CA2539324A1
(en)
*
|
2003-09-18 |
2005-03-31 |
Macusight, Inc. |
Transscleral delivery
|
|
NZ581461A
(en)
*
|
2003-11-13 |
2011-04-29 |
Psivida Inc |
Injectable sustained release delivery devices
|
|
KR20060109947A
(ko)
|
2003-11-20 |
2006-10-23 |
오쎄라 파마슈티걸즈, 인크. |
황반 변성 및 다른 안과 질환의 개선
|
|
US20050148948A1
(en)
*
|
2003-12-19 |
2005-07-07 |
Caputa Steven G. |
Sutureless ophthalmic drug delivery system and method
|
|
US8162897B2
(en)
*
|
2003-12-19 |
2012-04-24 |
Ethicon Endo-Surgery, Inc. |
Audible and tactile feedback
|
|
DE10360185A1
(de)
*
|
2003-12-20 |
2005-08-04 |
Max Wyssmann |
Vorrichtung zur gezielten, steuerbaren Abgabe oder zum Ansaugen einer Flüssigkeit oder einer viskosen Masse
|
|
US20050158365A1
(en)
*
|
2003-12-22 |
2005-07-21 |
David Watson |
Drug delivery device with mechanical locking mechanism
|
|
US20050137538A1
(en)
|
2003-12-22 |
2005-06-23 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
US7211272B2
(en)
*
|
2003-12-22 |
2007-05-01 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
US20050136095A1
(en)
*
|
2003-12-22 |
2005-06-23 |
Brian Levy |
Drug delivery device with suture ring
|
|
WO2005070333A1
(en)
*
|
2004-01-13 |
2005-08-04 |
Orthobiologica, Inc. |
Drug delivery to a joint
|
|
EP1718274A2
(en)
*
|
2004-01-26 |
2006-11-08 |
Control Delivery Systems, Inc. |
Controlled and sustained delivery of nucleic acid-based therapeutic agents
|
|
WO2005074894A1
(en)
|
2004-01-30 |
2005-08-18 |
Corium International |
Rapidly dissolving film for delivery of an active agent
|
|
US20060018949A1
(en)
*
|
2004-04-07 |
2006-01-26 |
Bausch & Lomb Incorporated |
Injectable biodegradable drug delivery system
|
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
|
WO2005115375A1
(en)
*
|
2004-05-25 |
2005-12-08 |
Othera Pharmaceuticals, Inc. |
Oculoselective drugs and prodrugs
|
|
EP2803357B1
(en)
|
2004-06-25 |
2020-11-18 |
The Johns-Hopkins University |
Angiogenesis inhibitors
|
|
US20060110428A1
(en)
*
|
2004-07-02 |
2006-05-25 |
Eugene Dejuan |
Methods and devices for the treatment of ocular conditions
|
|
DK1765454T3
(en)
|
2004-07-02 |
2016-05-02 |
Mati Therapeutics Inc |
Device for submission of treatment medium to eye
|
|
MX2007001512A
(es)
*
|
2004-08-05 |
2007-04-20 |
Corium Int Inc |
Composicion adhesiva.
|
|
US20060068012A1
(en)
*
|
2004-09-29 |
2006-03-30 |
Bausch & Lomb Incorporated |
Process for preparing poly (vinyl alcohol) drug delivery devices with humidity control
|
|
US20060067978A1
(en)
*
|
2004-09-29 |
2006-03-30 |
Bausch & Lomb Incorporated |
Process for preparing poly(vinyl alcohol) drug delivery devices
|
|
WO2006039459A1
(en)
*
|
2004-09-30 |
2006-04-13 |
Bausch & Lomb Incorporated |
Capsule for encasing tablets for surgical insertion into the human body
|
|
WO2006039333A1
(en)
*
|
2004-09-30 |
2006-04-13 |
Bausch & Lomb Incorporated |
Ophthalmic drug release device for multiple drug release
|
|
US20060078592A1
(en)
*
|
2004-10-12 |
2006-04-13 |
Bausch & Lomb Incorporated |
Drug delivery systems
|
|
US20070276481A1
(en)
*
|
2004-12-08 |
2007-11-29 |
Renner Steven B |
Drug delivery device
|
|
US20060134162A1
(en)
*
|
2004-12-16 |
2006-06-22 |
Larson Christopher W |
Methods for fabricating a drug delivery device
|
|
US20060166361A1
(en)
*
|
2004-12-21 |
2006-07-27 |
Agnieszka Seyda |
Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
|
|
US20060171930A1
(en)
*
|
2004-12-21 |
2006-08-03 |
Agnieszka Seyda |
Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same
|
|
US20060153815A1
(en)
*
|
2004-12-21 |
2006-07-13 |
Agnieszka Seyda |
Tissue engineering devices for the repair and regeneration of tissue
|
|
US20060135918A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Reusable drug delivery device
|
|
US20060134174A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
|
US20060134175A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Stephen Bartels |
Drug eluting pharmaceutical delivery system for treatment of ocular disease and method of use
|
|
US20060134176A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
|
CA2589041C
(en)
|
2004-12-23 |
2019-08-20 |
DePuy Synthes Products, Inc. |
Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
|
|
EP1835924B1
(en)
|
2004-12-23 |
2013-08-21 |
Ethicon, Incorporated |
Treatment of parkinson's disease and related disorders using postpartum derived cells
|
|
US8663639B2
(en)
*
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
JP4974903B2
(ja)
*
|
2005-02-09 |
2012-07-11 |
参天製薬株式会社 |
疾患または状態を処置するための液体処方物
|
|
KR20070121754A
(ko)
*
|
2005-03-21 |
2007-12-27 |
마커사이트, 인코포레이티드 |
질환 또는 상태의 치료를 위한 약물 송달 시스템
|
|
US8003124B2
(en)
*
|
2005-04-08 |
2011-08-23 |
Surmodics, Inc. |
Sustained release implants and methods for subretinal delivery of bioactive agents to treat or prevent retinal disease
|
|
US20080312283A1
(en)
*
|
2005-05-26 |
2008-12-18 |
Othera Pharmaceuticals, Inc. |
Use of Hydroxylamine Derivates for Inhibiting Vitrectomy-Induced Cataracts
|
|
US7651483B2
(en)
*
|
2005-06-24 |
2010-01-26 |
Ethicon Endo-Surgery, Inc. |
Injection port
|
|
US7918844B2
(en)
|
2005-06-24 |
2011-04-05 |
Ethicon Endo-Surgery, Inc. |
Applier for implantable medical device
|
|
US20060292202A1
(en)
*
|
2005-06-27 |
2006-12-28 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
AU2006272497B2
(en)
|
2005-07-27 |
2012-07-19 |
University Of Florida Research Foundation, Inc. |
Small compounds that correct protein misfolding and uses thereof
|
|
US20070212397A1
(en)
*
|
2005-09-15 |
2007-09-13 |
Roth Daniel B |
Pharmaceutical delivery device and method for providing ocular treatment
|
|
HRP20100559T1
(hr)
|
2005-11-29 |
2010-11-30 |
Glaxosmithkline Llc |
Liječenje neovaskularnih poremećaja oka, poput makularne degeneracije, angioidnih strija, uveitisa i edema makule
|
|
WO2007070870A1
(en)
*
|
2005-12-16 |
2007-06-21 |
Ethicon, Inc. |
Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation
|
|
US9125906B2
(en)
|
2005-12-28 |
2015-09-08 |
DePuy Synthes Products, Inc. |
Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
|
|
EP1979050B1
(en)
*
|
2005-12-28 |
2017-04-19 |
DePuy Synthes Products, Inc. |
Treatment of peripheral vascular disease using postpartum-derived cells
|
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
|
WO2007092620A2
(en)
|
2006-02-09 |
2007-08-16 |
Macusight, Inc. |
Stable formulations, and methods of their preparation and use
|
|
US20070203190A1
(en)
*
|
2006-02-22 |
2007-08-30 |
Ghanshyam Patil |
Hydroxylamines and derivatives for the inhibition of complement activation
|
|
PL2001466T3
(pl)
|
2006-03-23 |
2016-06-30 |
Santen Pharmaceutical Co Ltd |
Rapamycyna w małej dawce do leczenia chorób związanych z przepuszczalnością naczyń
|
|
EP2004172B1
(en)
|
2006-03-31 |
2019-03-13 |
Mati Therapeutics Inc. |
Drug delivery structures and compositions for nasolacrimal system
|
|
US20090130212A1
(en)
*
|
2006-05-15 |
2009-05-21 |
Physical Pharmaceutica, Llc |
Composition and improved method for preparation of small particles
|
|
PT2029746E
(pt)
*
|
2006-06-12 |
2012-10-15 |
Exegenics Inc D B A Opko Health Inc |
Composições e métodos para a inibição do sirna de angiogenese
|
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US8802128B2
(en)
*
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
SG174031A1
(en)
*
|
2006-08-07 |
2011-09-29 |
Bausch & Lomb |
Treating infections and sequelae thereof with combined dissociated' glucocorticoid receptor agonists and anti-infective agents
|
|
PL2056799T3
(pl)
*
|
2006-08-31 |
2014-01-31 |
Bausch & Lomb |
Kompozycje i sposoby do leczenia lub zapobiegania jaskrze lub jej rozwojowi
|
|
US7872118B2
(en)
*
|
2006-09-08 |
2011-01-18 |
Opko Ophthalmics, Llc |
siRNA and methods of manufacture
|
|
US20110105559A1
(en)
*
|
2006-09-11 |
2011-05-05 |
Rohrs Brian R |
Compositions and Methods for Treating, Controlling, Reducing, Ameliorating, or Preventing Allergy
|
|
CA2661197C
(en)
*
|
2006-09-11 |
2012-01-03 |
Bausch & Lomb Incorporated |
Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy
|
|
US20110104159A1
(en)
*
|
2006-09-11 |
2011-05-05 |
Rohrs Brian R |
Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy
|
|
US20080145405A1
(en)
*
|
2006-12-15 |
2008-06-19 |
Kunzler Jay F |
Drug delivery devices
|
|
GB0713463D0
(en)
|
2007-07-11 |
2007-08-22 |
Btg Int Ltd |
Modulators of hypoxia inducible factor-1 and related uses
|
|
EP2620429A1
(en)
|
2007-02-22 |
2013-07-31 |
Colby Pharmaceutical Company |
Hydroxylamine compounds and methods of their use
|
|
US20080265343A1
(en)
*
|
2007-04-26 |
2008-10-30 |
International Business Machines Corporation |
Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
|
|
US20090042936A1
(en)
*
|
2007-08-10 |
2009-02-12 |
Ward Keith W |
Compositions and Methods for Treating or Controlling Anterior-Segment Inflammation
|
|
US20090087443A1
(en)
|
2007-09-27 |
2009-04-02 |
Bartels Stephen P |
Pharmacological Adjunctive Treatment Associated with Glaucoma Filtration Surgery
|
|
ES2525718T3
(es)
*
|
2007-10-05 |
2014-12-29 |
DePuy Synthes Products, LLC |
Reparación y regeneración de tejido renal mediante células derivadas de tejido de cordón umbilical humano
|
|
US20100152646A1
(en)
*
|
2008-02-29 |
2010-06-17 |
Reshma Girijavallabhan |
Intravitreal injection device and method
|
|
RU2464048C2
(ru)
|
2008-04-17 |
2012-10-20 |
Аллерган, Инк. |
Имплантируемый порт доступа и система его крепления
|
|
US9023063B2
(en)
|
2008-04-17 |
2015-05-05 |
Apollo Endosurgery, Inc. |
Implantable access port device having a safety cap
|
|
US20090291073A1
(en)
*
|
2008-05-20 |
2009-11-26 |
Ward Keith W |
Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same
|
|
US20100121441A1
(en)
*
|
2008-11-10 |
2010-05-13 |
Nabil Jabbour |
Surgical implant and method
|
|
JP5832293B2
(ja)
|
2008-12-04 |
2015-12-16 |
オプコ ファーマシューティカルズ、エルエルシー |
血管新生促進ｖｅｇｆイソ型を選択的に抑制する組成物および方法
|
|
WO2010077732A2
(en)
*
|
2008-12-09 |
2010-07-08 |
Aether Medical Llc |
Implantable analgesic
|
|
CN102458425A
(zh)
*
|
2008-12-19 |
2012-05-16 |
伊西康公司 |
损伤后神经组织的再生和修复
|
|
US10179900B2
(en)
*
|
2008-12-19 |
2019-01-15 |
DePuy Synthes Products, Inc. |
Conditioned media and methods of making a conditioned media
|
|
JP5518893B2
(ja)
|
2008-12-19 |
2014-06-11 |
アドバンスト・テクノロジーズ・アンド・リジェネレイティブ・メディスン・エルエルシー |
肺ならびに肺の疾患および障害の治療
|
|
EP2379087B1
(en)
*
|
2008-12-19 |
2014-08-20 |
DePuy Synthes Products, LLC |
Umbilical cord tissue derived cells for treating neuropathic pain and spasticity
|
|
CA2751884C
(en)
|
2009-01-14 |
2018-09-25 |
Corium International, Inc. |
Transdermal administration of tamsulosin
|
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
US8399006B2
(en)
|
2009-01-29 |
2013-03-19 |
Forsight Vision4, Inc. |
Posterior segment drug delivery
|
|
WO2010093945A2
(en)
|
2009-02-13 |
2010-08-19 |
Glaukos Corporation |
Uveoscleral drug delivery implant and methods for implanting the same
|
|
EP2411504B1
(en)
|
2009-03-26 |
2017-05-10 |
DePuy Synthes Products, Inc. |
Human umbilical cord tissue cells as therapy for alzheimer's disease
|
|
US20110077270A1
(en)
*
|
2009-04-21 |
2011-03-31 |
Pfeffer Bruce A |
Compositions and Methods for Treating Ocular Inflammation with Lower Risk of Increased Intraocular Pressure
|
|
US8372036B2
(en)
*
|
2009-05-06 |
2013-02-12 |
Alcon Research, Ltd. |
Multi-layer heat assembly for a drug delivery device
|
|
CA3186189A1
(en)
*
|
2009-05-18 |
2010-11-25 |
Dose Medical Corporation |
Drug eluting ocular implant
|
|
US12478503B2
(en)
|
2009-05-18 |
2025-11-25 |
Glaukos Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
WO2015073571A1
(en)
*
|
2013-11-15 |
2015-05-21 |
Dose Medical Corporation |
Ocular implants configured to store and release stable drug formulations
|
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
EP2437684B1
(en)
|
2009-06-03 |
2022-06-15 |
ForSight Vision5, Inc. |
Anterior segment drug delivery
|
|
IN2012DN00352A
(sr)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
|
US8506532B2
(en)
|
2009-08-26 |
2013-08-13 |
Allergan, Inc. |
System including access port and applicator tool
|
|
US8708979B2
(en)
|
2009-08-26 |
2014-04-29 |
Apollo Endosurgery, Inc. |
Implantable coupling device
|
|
US8715158B2
(en)
|
2009-08-26 |
2014-05-06 |
Apollo Endosurgery, Inc. |
Implantable bottom exit port
|
|
US20120232102A1
(en)
|
2009-09-30 |
2012-09-13 |
Chun-Fang Xu |
Methods Of Administration And Treatment
|
|
RU2012127772A
(ru)
*
|
2009-12-04 |
2014-01-10 |
ОПКО ОФТЭЛМИКС, ЭлЭлСи |
Композиции и способы для ингибирования vegf
|
|
US8177747B2
(en)
*
|
2009-12-22 |
2012-05-15 |
Alcon Research, Ltd. |
Method and apparatus for drug delivery
|
|
WO2011079232A1
(en)
*
|
2009-12-23 |
2011-06-30 |
Psivida Us, Inc. |
Sustained release delivery devices
|
|
US10166142B2
(en)
|
2010-01-29 |
2019-01-01 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
|
US20110189174A1
(en)
*
|
2010-02-01 |
2011-08-04 |
Afshin Shafiee |
Compositions and methods for treating, reducing, ameliorating, alleviating, or inhibiting progression of, pathogenic ocular neovascularization
|
|
US8882728B2
(en)
|
2010-02-10 |
2014-11-11 |
Apollo Endosurgery, Inc. |
Implantable injection port
|
|
US8992415B2
(en)
|
2010-04-30 |
2015-03-31 |
Apollo Endosurgery, Inc. |
Implantable device to protect tubing from puncture
|
|
US20110270021A1
(en)
|
2010-04-30 |
2011-11-03 |
Allergan, Inc. |
Electronically enhanced access port for a fluid filled implant
|
|
US20110270025A1
(en)
|
2010-04-30 |
2011-11-03 |
Allergan, Inc. |
Remotely powered remotely adjustable gastric band system
|
|
CA2798084A1
(en)
*
|
2010-05-17 |
2011-11-24 |
Aerie Pharmaceuticals, Inc. |
Drug delivery devices for delivery of ocular therapeutic agents
|
|
WO2011163560A1
(en)
|
2010-06-25 |
2011-12-29 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Methods of treatment using sterculic acid
|
|
EP3861969A1
(en)
|
2010-08-05 |
2021-08-11 |
ForSight Vision4, Inc. |
Injector apparatus for drug delivery
|
|
JP6111194B2
(ja)
|
2010-08-05 |
2017-04-05 |
フォーサイト・ビジョン フォー・インコーポレーテッド |
組み合わせ薬物送達方法および装置
|
|
SI2600812T1
(sl)
|
2010-08-05 |
2021-12-31 |
ForSight Vision4, Inc., |
Naprava za zdravljenje očesa
|
|
US20120041258A1
(en)
|
2010-08-16 |
2012-02-16 |
Allergan, Inc. |
Implantable access port system
|
|
US20120065460A1
(en)
|
2010-09-14 |
2012-03-15 |
Greg Nitka |
Implantable access port system
|
|
WO2012068549A2
(en)
|
2010-11-19 |
2012-05-24 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
|
US9668915B2
(en)
|
2010-11-24 |
2017-06-06 |
Dose Medical Corporation |
Drug eluting ocular implant
|
|
EP2651399A2
(en)
|
2010-12-13 |
2013-10-23 |
Purdue Pharma LP |
Controlled release dosage forms
|
|
US8821373B2
(en)
|
2011-05-10 |
2014-09-02 |
Apollo Endosurgery, Inc. |
Directionless (orientation independent) needle injection port
|
|
US10245178B1
(en)
|
2011-06-07 |
2019-04-02 |
Glaukos Corporation |
Anterior chamber drug-eluting ocular implant
|
|
US20120316199A1
(en)
|
2011-06-07 |
2012-12-13 |
Ward Keith W |
Compositions and methods for treating, controlling, reducing, or ameliorating inflammatory pain
|
|
EA032666B1
(ru)
|
2011-06-14 |
2019-06-28 |
Бикам Фармасьютикалз, Инк. |
Опсинсвязывающие лиганды и способы их применения
|
|
EP4249059B1
(en)
|
2011-06-28 |
2025-07-30 |
ForSight Vision4, Inc. |
An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye
|
|
US8801597B2
(en)
|
2011-08-25 |
2014-08-12 |
Apollo Endosurgery, Inc. |
Implantable access port with mesh attachment rivets
|
|
ES2727203T3
(es)
|
2011-08-29 |
2019-10-14 |
Mati Therapeutics Inc |
Administración por liberación sostenida de agentes activos para tratar glaucoma e hipertensión ocular
|
|
US9974685B2
(en)
|
2011-08-29 |
2018-05-22 |
Mati Therapeutics |
Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
|
|
EP2755615B1
(en)
|
2011-09-14 |
2022-04-06 |
Forsight Vision5, Inc. |
Ocular insert apparatus
|
|
RS61758B1
(sr)
|
2011-09-16 |
2021-05-31 |
Forsight Vision4 Inc |
Aparati za razmenu tečnosti
|
|
CA2856703A1
(en)
|
2011-10-19 |
2013-04-25 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
US9199069B2
(en)
|
2011-10-20 |
2015-12-01 |
Apollo Endosurgery, Inc. |
Implantable injection port
|
|
US8858421B2
(en)
|
2011-11-15 |
2014-10-14 |
Apollo Endosurgery, Inc. |
Interior needle stick guard stems for tubes
|
|
US9089395B2
(en)
|
2011-11-16 |
2015-07-28 |
Appolo Endosurgery, Inc. |
Pre-loaded septum for use with an access port
|
|
AU2012346214B2
(en)
|
2011-11-30 |
2017-09-14 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
JP6322142B2
(ja)
|
2011-12-01 |
2018-05-09 |
ビカム ファーマスーティカルス，インコーポレイテッド |
オプシン結合性リガンド、組成物、及び使用方法
|
|
EP2794854B1
(en)
|
2011-12-23 |
2018-06-20 |
DePuy Synthes Products, Inc. |
Detection of human umbilical cord tissue-derived cells
|
|
US9364316B1
(en)
*
|
2012-01-24 |
2016-06-14 |
Clarvista Medical, Inc. |
Modular intraocular lens designs, tools and methods
|
|
CA2861865C
(en)
|
2012-01-24 |
2020-12-29 |
The Regents Of The University Of Colorado, A Body Corporate |
Modular intraocular lens designs and methods
|
|
US10080648B2
(en)
|
2012-01-24 |
2018-09-25 |
Clarvista Medical, Inc. |
Modular intraocular lens designs, tools and methods
|
|
US10028824B2
(en)
|
2012-01-24 |
2018-07-24 |
Clarvista Medical, Inc. |
Modular intraocular lens designs, tools and methods
|
|
US10010448B2
(en)
|
2012-02-03 |
2018-07-03 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
|
KR101969594B1
(ko)
*
|
2012-05-11 |
2019-04-16 |
서강대학교산학협력단 |
안내 약물 전달 임플란트
|
|
DK2911623T3
(da)
|
2012-10-26 |
2019-10-28 |
Forsight Vision5 Inc |
Oftalmisk system til langvarig frigivelse af lægemiddel til øjet
|
|
US10981961B2
(en)
|
2013-03-11 |
2021-04-20 |
University Of Florida Research Foundation, Incorporated |
Delivery of card protein as therapy for occular inflammation
|
|
CA2905496A1
(en)
|
2013-03-14 |
2014-09-25 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
|
US10517759B2
(en)
|
2013-03-15 |
2019-12-31 |
Glaukos Corporation |
Glaucoma stent and methods thereof for glaucoma treatment
|
|
ES2972168T3
(es)
|
2013-03-28 |
2024-06-11 |
Forsight Vision4 Inc |
Implante oftálmico para administración de sustancias terapéuticas
|
|
EP2991621B1
(en)
|
2013-05-02 |
2020-12-09 |
Retina Foundation of the Southwest |
Two-layer ocular implant
|
|
CA2929684C
(en)
*
|
2013-11-14 |
2022-02-22 |
Jean-Marie Rakic |
Eye device
|
|
CA2938966C
(en)
|
2014-02-18 |
2023-03-14 |
Clarvista Medical, Inc. |
Modular intraocular lens designs, tools and methods
|
|
EP3677229A1
(en)
|
2014-05-29 |
2020-07-08 |
Glaukos Corporation |
Implants with controlled drug delivery features
|
|
US9580896B2
(en)
|
2014-07-05 |
2017-02-28 |
John David Hopkins |
Apparatus and method for prolonged active agent in aqueous systems
|
|
EP3169289B1
(en)
|
2014-07-15 |
2020-04-15 |
ForSight Vision4, Inc. |
Ocular implant delivery device
|
|
BR112017002466A2
(pt)
|
2014-08-08 |
2017-12-05 |
Forsight Vision4 Inc |
formulações estáveis e solúveis de inibidores da tirosina cinase do receptor, e métodos para a sua preparação
|
|
WO2016077371A1
(en)
|
2014-11-10 |
2016-05-19 |
Forsight Vision4, Inc. |
Expandable drug delivery devices and method of use
|
|
CA3239477A1
(en)
|
2015-01-30 |
2016-08-04 |
Alcon, Inc. |
Modular intraocular lens designs, tools and methods
|
|
US20160296532A1
(en)
|
2015-04-13 |
2016-10-13 |
Forsight Vision5, Inc. |
Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
|
|
US11925578B2
(en)
|
2015-09-02 |
2024-03-12 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
|
WO2017053885A1
(en)
|
2015-09-25 |
2017-03-30 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
|
US11458041B2
(en)
|
2015-10-08 |
2022-10-04 |
Ocular Therapeutix, Inc. |
Punctal plug and bioadhesives
|
|
CN108348327B
(zh)
|
2015-11-04 |
2021-10-01 |
克拉维斯塔医疗有限公司 |
模块化人工晶状体设计、工具和方法
|
|
CA3005238A1
(en)
|
2015-11-20 |
2017-05-26 |
Forsight Vision4, Inc. |
Porous structures for extended release drug delivery devices
|
|
JP7009384B2
(ja)
|
2016-04-05 |
2022-01-25 |
フォーサイト・ビジョン フォー・インコーポレーテッド |
移植可能な眼薬送達デバイス
|
|
EP3442479B1
(en)
|
2016-04-20 |
2026-03-04 |
Glaukos Corporation |
Bioresorbable ocular drug delivery device
|
|
US11045309B2
(en)
|
2016-05-05 |
2021-06-29 |
The Regents Of The University Of Colorado |
Intraocular lens designs for improved stability
|
|
MX2019000050A
(es)
|
2016-07-05 |
2019-05-02 |
Janssen Biotech Inc |
Tratamiento de la enfermedad vascular retinal mediante el uso de celulas progenitoras.
|
|
WO2018231811A1
(en)
|
2017-06-13 |
2018-12-20 |
EyePoint Pharmaceuticals, Inc. |
Bioerodible drug delivery devices
|
|
US11382736B2
(en)
|
2017-06-27 |
2022-07-12 |
Alcon Inc. |
Injector, intraocular lens system, and related methods
|
|
US11103460B2
(en)
|
2017-08-07 |
2021-08-31 |
Board Of Regents, The University Of Texas System |
Fabrication methods for nanodelivery systems for long term controlled delivery of active pharmaceutical ingredients
|
|
KR20200093581A
(ko)
|
2017-11-21 |
2020-08-05 |
포사이트 비젼4, 인크. |
확장 가능한 포트 전달 시스템을 위한 유체 교환 기기 및 사용 방법
|
|
KR20260007295A
(ko)
|
2018-05-24 |
2026-01-13 |
셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 |
거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치
|
|
US11689849B2
(en)
|
2018-05-24 |
2023-06-27 |
Nureva, Inc. |
Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
|
|
US11690806B2
(en)
|
2018-05-24 |
2023-07-04 |
Celanese Eva Performance Polymers Llc |
Implantable device for sustained release of a macromolecular drug compound
|
|
US11779739B2
(en)
*
|
2018-12-21 |
2023-10-10 |
Perfect Ip, Llc |
Drug delivery system and method
|
|
US12491264B2
(en)
|
2019-03-04 |
2025-12-09 |
Duke University |
Compositions and methods for the diagnosis and treatment of retinopathies
|
|
CA3166738A1
(en)
|
2020-02-06 |
2021-08-12 |
Charles D. Blizzard |
Travoprost compositions and methods for treating ocular diseases
|
|
US20240374599A1
(en)
|
2020-02-26 |
2024-11-14 |
Case Western Reserve University |
Compositions and methods for treating misfolded protein ocular disorders
|
|
EP3884929B1
(en)
|
2020-03-25 |
2023-06-14 |
Ocular Therapeutix, Inc. |
Ocular implant containing a tyrosine kinase inhibitor
|
|
WO2021222117A1
(en)
|
2020-04-27 |
2021-11-04 |
Ocular Therapeutix, Inc. |
Methods of treating allergic conjunctivitis
|
|
TWI910236B
(zh)
|
2020-09-24 |
2026-01-01 |
美商視爾普斯眼科公司 |
包含水凝膠及環孢菌素之持續釋放可生物降解淚小管內插入物
|
|
EP4216929A1
(en)
|
2020-09-24 |
2023-08-02 |
Ocular Therapeutix, Inc. |
Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agent
|
|
BR112023022439A2
(pt)
|
2021-04-26 |
2023-12-26 |
Celanese Eva Performance Polymers Llc |
Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular
|
|
US11357620B1
(en)
|
2021-09-10 |
2022-06-14 |
California LASIK & Eye, Inc. |
Exchangeable optics and therapeutics
|
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|
|
CN120897764A
(zh)
|
2023-04-11 |
2025-11-04 |
视尔普斯眼科公司 |
包含阿西替尼多晶型物iv的眼部植入物
|